INDV Earnings

Quarterly EPS
$0.16
Q3 2024
$0.17
Q4 2024
$0.38
Q1 2025
$0.15
Q2 2025
$0.34
Q3 2025
$0.81
Q4 2025
$0.71
Q1 2026
$1.02
Q2 2026
Latest Revenue343.0M
Latest Net Income122.0M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$1.02343.0M122.0M+13.6%+580.0%
Q1 2026$0.71317.0M89.0M+19.2%+86.8%
Q4 2025$0.81358.0M102.0M+19.7%+376.5%
Q3 2025$0.34314.0M42.0M+2.3%+112.5%
Q2 2025$0.15302.0M18.0M+1.0%+120.8%
Q1 2025$0.38266.0M48.0M-6.3%-15.6%
Q4 2024$0.17299.0M21.0M
Q3 2024$0.16307.0M22.0M
Q2 2024-$0.72299.0M-97000000
Q1 2024$0.45284.0M62.0M
Indivior Pharmaceuticals (INDV) — Earnings